CAST PHARMA Announces a New Office in Denmark

CAST PHARMACAST PHARMA, a premier European 3D pharmaceutical and biomedical animation production company, has announced the opening of the new office in Ballerup, Denmark. This new office will allow Cast Pharma to meet the growing demand in the Northern Europe pharmaceutical market and to improve services to existing clients.

"With the increase in technology capabilities and the rapidly growing demand on patient education as well as the health care professionals' continuous training needs, more and more pharmaceutical companies are moving to 3D visualization techniques to get their message across to their target audience and differentiate themselves from their competitors," commented CAST PHARMA owner, Mr. Stefan Wolf. "Our new office is represented by Mrs. Antje Madsen, a skilled, top line professional that will better serve our European clients and will allow us to meet the increasing demands of 3D mode of action animation production."

With the extended capabilities of its new office, CAST PHARMA will focus on promoting its advanced services and increasing its client base in the Northern Europe region. Over the last few years, CAST PHARMA has positioned itself as an unique, advanced and highly professional company on the German pharmaceutical market. As result, this growing is a perfect fit for CAST PHARMA to expand its services and to position itself as the leading and the premier European 3D pharmaceutical and biomedical animation production company.

For further information, please visit:
http://www.cast-pharma.com

About CAST PHARMA
CAST PHARMA ia a premier European 3D pharmaceutical and biomedical animation production company. For more information, please visit www.cast-pharma.com.

Source: PharmaNews.eu

Most Popular Now

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Pfizer invests $43 billion to battle cancer

Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a...

Pfizer's ZAVZPRET™ (zavegepant) migraine nasal spr…

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptid...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Scientists reveal a potential new approach to trea…

Scientists at the National Institutes of Health and Massachusetts General Hospital in Boston have uncovered a potential new approach against liver cancer that could lead ...

Normalizing tumor blood vessels may improve immuno…

A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited e...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...